Isracann Biosciences (IPOT.C) did more work in three months than some companies did in a year

There’s a lot going on underneath the surface with Isracann Biosciences (IPOT.C).  A year in review won’t be much, mostly because this company hasn’t been public for a year. Instead, it’s more like a quarter-in-review, as the company only rolled into Atlas Blockchain, going public on the CSE (and OTC exchange as ISCNF) in October of 2019, but what makes this (and them) noteworthy is what they’ve managed to build for themselves in such a short timespan.

Organigram Holdings (OGI.V) ships their first cannabis 2.0 product to stores, but will anyone care?

So October 17th came and went and if you didn’t notice any new edibles (or beverages, etc) at your local dispensary, that’s by design. Back in June, we wrote a little story about cannabis edibles on the eve of Health Canada’s pontifications regarding the industry and how will be regulated. The first anniversary of legalization day inaugurated cannabis 2.0, in which cannabis companies could start sending their proposed formulations to regulator to given the official nod or denial. Accompanying this was a 60 day hold before companies could start putting products on shelves.